CryoConcepts Funding: How Much Did They Raise & Key Investors

How Much Did CryoConcepts Raise?
Funding & Key Investors

CryoConcepts has solidified its position as a dominant force in the medical device sector, securing a total capital infusion of $784K. This trajectory of financial growth is underscored by a recent strategic investment of $434K, which serves to bolster the company's operational capacity and global distribution network. By leveraging these debt-based financing rounds, the firm continues to scale its proprietary cryosurgery and cryotherapy platforms, ensuring sustained liquidity for its expansive international operations.

What is CryoConcepts?

CryoConcepts

Manufacturing

Medical Devices & Equipment

Established in 1991, CryoConcepts operates at the intersection of medical innovation and consumer health. The company is recognized for its comprehensive portfolio of cryo-based solutions, which span the OTC, medical, aesthetic, and veterinary markets. Its flagship Histofreezer brand remains a cornerstone of its market presence, supported by a suite of FDA-cleared at-home cryo treatments. With a footprint extending across 40 countries, CryoConcepts maintains a robust competitive advantage through strategic partnerships with global consumer product entities, effectively bridging the gap between clinical-grade cryotherapy and accessible, patient-centric care.

How much funding has CryoConcepts raised?

CryoConcepts has raised a total of $784K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$434K

Debt (2020): $350K with participation from PPP

Debt (2021): $434K led by PPP

Key Investors in CryoConcepts

PPP

Public-Private Partnership

Undisclosed Investors

What's next for CryoConcepts?

The recent influx of capital positions CryoConcepts to accelerate its R&D initiatives and deepen its penetration into emerging aesthetic and veterinary markets. As the company transitions into a more mature enterprise-level lifecycle, the focus will likely shift toward optimizing supply chain efficiencies and expanding its regulatory approvals in new jurisdictions. By maintaining its commitment to high-quality, innovative cryo-based products, CryoConcepts is well-equipped to navigate the evolving landscape of non-invasive dermatological treatments and beyond, ensuring long-term value creation for its stakeholders and partners.

See full CryoConcepts company page

See More Financial Insights